Interestingly, TGF-β, which is secreted by tumor cells and tumor-infiltrating regulatory T cells [77–79], enhances the expression of chemokine receptors CCR1, CCR3, CCR5, CCR6, and CXCR4 on DCs, thereby driving DC migration to the TME. The gene discussed is CCR5; the disease is neoplasm.